4-氟-2-甲氧基苯乙酮 | 51788-80-8

• 物质功能分类: 有机原料 - 酮类化合物
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 4-氟-2-甲氧基苯乙酮
• 中文别名: 2-甲氧基-4-氟苯乙酮；2'-甲氧基-4'-氟苯乙酮
• 英文名称: 1-(4-fluoro-2-methoxy-phenyl)-ethanone
• 英文别名: 4-fluoro-2-methoxyacetophenone；1-(4-fluoro-2-methoxyphenyl)ethanone
• CAS: 51788-80-8
• 化学式: C₉H₉FO₂
• 分子量: 168.168
• InChiKey: YOXBPWVWNQROBJ-UHFFFAOYSA-N

物化性质

• 熔点：
  51 °C
• 沸点：
  228.4±20.0 °C(Predicted)
• 密度：
  1.127±0.06 g/cm3(Predicted)
• 稳定性/保质期：

  如果按照规格使用和储存，则不会分解，未有已知危险反应。

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 安全说明：
  S26,S36/37/39
• 海关编码：
  2914700090
• 危险品标志：
  Xi
• 危险类别码：
  R36/37/38
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  请将贮藏器密封存放于阴凉、干燥处，并确保工作环境有良好的通风或排气设施。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
4’-Fluoro-2’-methoxyacetophenone
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
4’-Fluoro-2’-methoxyacetophenone
Ingredient name:
CAS number: 51788-80-8

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C9H9FO2
Molecular weight: 168.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-氟-2-甲氧基苯乙酮 在 溴 、 sodium hydride 、 potassium carbonate 作用下， 以 四氢呋喃 、 甲基叔丁基醚 、 N,N-二甲基甲酰胺 为溶剂， 反应 6.5h， 生成 1-[4-(4-chlorophenoxy)-2-methoxy-phenyl]-2-(1,2,4-triazol-1-yl)ethanone
  参考文献：
  名称：

  [EN] SUBSTITUTED [1,2,4]TRIAZOLE COMPOUNDS
  [FR] COMPOSÉS DE [1,2,4]TRIAZOLE SUBSTITUÉS

  摘要：

  本发明涉及替代[1,2,4]三唑化合物的公式(I)，其中取代基在权利要求和描述中定义，以及其N-氧化物和盐，用于对抗植物病原真菌，以及用于对抗植物病原真菌的使用和方法，以及至少涂覆有一种这样的化合物的种子。该发明还涉及制备这些化合物的过程，中间体，制备这种中间体的过程，以及包含至少一种化合物I的组合物。

  公开号：

  WO2014082872A1
• 作为产物：
  描述：

  3-氟苯酚 在 吡啶 、 三氯化铝 、 sodium hydride 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 2.0h， 生成 4-氟-2-甲氧基苯乙酮
  参考文献：
  名称：

  咪唑并[1,2-a]嘧啶和咪唑并[1,2-a]吡嗪：氮位置在正性肌力活动中的作用。

  摘要：

  充血性心力衰竭是主要的医学问题，现有药物对其提供的益处有限。最近的新实验药物，包括咪唑并[4,5-b]-和咪唑并[4,5-c]吡啶，具有正性肌力和血管舒张性。这些化合物氮位置的细微变化已显示出会显着影响效能。我们合成了一系列咪唑[4,5-b]-和-[4,5-c]吡啶类似物，它们的咪唑氮原子位于桥头位置。我们的类似物的活性再次证明了[4,5-c]吡啶与[4,5-b]吡啶相比具有更好的正性肌力。证明了咪唑并[4,5-b]吡啶与咪唑并[1,2-a]嘧啶的生物等效性以及咪唑并[4,5-c]吡啶与咪唑并[1,2-a]吡嗪的生物学等效性。此外，2- [2-甲氧基-4-（甲基亚磺酰基）苯基]咪唑[1，

  DOI：

  10.1021/jm00403a018
• 作为试剂：
  描述：

  4’-氟-2-羟基苯乙酮 、 碘甲烷 、 、 sodium;hydride 、 N,N-二甲基甲酰胺 在 乙酸乙酯 、 4-氟-2-甲氧基苯乙酮 作用下， 反应 1.0h， 以provided a total of 28 g的产率得到4-氟-2-甲氧基苯乙酮
  参考文献：
  名称：

  Inotropic agents

  摘要：

  这项发明提供了某些苯基取代的咪唑化合物，它们的制药配方以及它们作为正性肌力药和血管扩张剂的用途。

  公开号：

  US04670445A1

文献信息

• [EN] MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DES RÉCEPTEURS MUSCARINIQUES DE L'ACÉTYLCHOLINE M1
  申请人：PIPELINE THERAPEUTICS INC

  公开号：WO2021071843A1

  公开（公告）日：2021-04-15

  Provided herein, inter alia, are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.

  本文提供了一些化合物，这些化合物可用作胆碱能乙酰胆碱受体M1（mAChR M1）的拮抗剂；制备这些化合物的合成方法；包含这些化合物的药物组合物；以及使用这些化合物和组合物治疗与胆碱能乙酰胆碱受体功能障碍相关的神经和精神疾病的方法。
• 2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
  申请人：Schering Corporation

  公开号：US20040220194A1

  公开（公告）日：2004-11-04

  Compounds having the structural formula I 1 or a pharmaceutically acceptable salt thereof, wherein R is 2 R 1 , R 2 , R 3 , R 4 and R 5 are H, alkyl or alkoxyalkyl; R 6 is H, alkyl, hydroxyalkyl or —CH 2 F; R 7 , R 8 and R 9 are H, alkyl, alkoxy, alkylthio, alkoxyalkyl, halo or —CF 3 ; and Z is optionally substituted aryl, heteroaryl or heteroaryl-alkyl are disclosed. Also disclosed is the use of compounds of formula I in the treatment of central nervous system diseases, in particular Parkinson's disease, alone or in combination with other agents for treating Parkinson's disease, and pharmaceutical compositions comprising them.

  具有结构式I或其药用可接受盐的化合物，其中R是R1，R2，R3，R4和R5为H，烷基或烷氧基烷基；R6为H，烷基，羟基烷基或—CH2F；R7，R8和R9为H，烷基，烷氧基，烷硫基，烷氧基烷基，卤素或—CF3；以及Z是可选择地取代的芳基，杂环芳基或杂环芳基烷基。还公开了化合物I的应用于治疗中枢神经系统疾病，特别是帕金森病，单独或与其他治疗帕金森病的药剂联合使用，以及包含它们的药物组合物。
• [EN] MODULATORS OF DOPAMINE NEUROTRANSMISSION<br/>[FR] MODULATEURS DE LA NEUROTRANSMISSION DE LA DOPAMINE
  申请人：NSAB AF NEUROSEARCH SWEDEN AB

  公开号：WO2009133110A1

  公开（公告）日：2009-11-05

  The present invention relates to novel1-(4H-1,3-benzodioxin-2-yl)methanamine derivatives, useful as modulators of dopamine neurotransmission, and more specifically asdopaminergic stabilizers. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.

  这项发明涉及一种新颖的1-(4H-1,3-苯并二氧杂环戊二烯-2-基)甲胺衍生物，可用作多巴胺神经传导调节剂，更具体地说是多巴胺稳定剂。在其他方面，该发明涉及将这些化合物用于治疗方法以及包含该发明化合物的药物组合物。
• Boron-Containing Small Molecules as Anti-Inflammatory Agents
  申请人：ANACOR PHARMACEUTICALS, INC.

  公开号：US20150291629A1

  公开（公告）日：2015-10-15

  Compounds and methods of treating anti-inflammatory conditions are disclosed.

  化合物和治疗抗炎症状况的方法被披露。
• Novel Synthesis of 6-Substituted 2-Picolines from Aryl/heteroaryl β-Enaminones and Meldrum's Acid Using CeCl₃.7H₂O/NaI
  作者：Dinesh Addla、Srinivas Kantevari

  DOI：10.1002/jhet.1941

  日期：2014.8

  One-pot condensation of aryl/heteroaryl β-enaminones, Meldrum's acid, and ammonium acetate in the presence of CeCl3.7H2O/NaI via tandem Michael addition–cyclodehydration–elimination sequence led to the formation of novel regioselective 6-substituted 2-picolines.

  一锅缩合的芳基/杂芳基β-烯胺酮，Meldrum酸和 CeCl 3 .7H 2 O / NaI存在下，通过串联迈克尔加成-环脱水-消除序列的乙酸铵导致形成新的区域选择性6取代的2-甲基吡啶。

表征谱图